Company Filing History:
1 out of 64 
1 out of 5,081 
1 out of 153 
Years Active: 2018
Title: Rob Ruigrok: Innovating in Viral Research
Introduction
Rob Ruigrok, an accomplished inventor based in Sassenage, France, has made significant contributions to the field of virology through his innovative research. With a focus on polypeptide fragments that exhibit endonuclease activity, Ruigrok's work aims to develop novel therapeutic strategies against viral infections.
Latest Patents
Rob Ruigrok holds a patent titled "Polypeptide fragments comprising endonuclease activity and their use." This groundbreaking invention encompasses polypeptide fragments containing an amino-terminal fragment of the PA subunit of a viral RNA-dependent RNA polymerase, particularly from viruses belonging to the Orthomyxoviridae family. The patent not only includes the structural characterization of these fragments but also presents computational methods for identifying compounds that can modulate or inhibit the endonucleolytically active site within the fragments. This innovation proposes methods for screening compounds to treat diseases caused by viruses from the Orthomyxoviridae family with a focus on high-throughput settings.
Career Highlights
Ruigrok's impressive career is highlighted by his experience at prestigious institutions such as the European Molecular Biology Laboratory (EMBL) and the Centre National De La Recherche Scientifique. His work has been pivotal in advancing our understanding of viral mechanisms and the potential for therapeutic interventions.
Collaborations
Throughout his career, Rob Ruigrok has collaborated with notable colleagues, including Denis Bouvier and Thibaut Crepin. These partnerships have further enriched his research and contributed to the collective knowledge within the field of virology.
Conclusion
Rob Ruigrok continues to pave the way for advancements in viral research with his innovative patents and collaborations. His contributions to the understanding of endonuclease activity in viral RNA-dependent RNA polymerases represent a significant step toward developing effective treatments for viral infections. Through his dedication, Ruigrok exemplifies the spirit of innovation within the scientific community.